Pyrotinib,Trastuzumab,Docetaxel
jiangsu hengrui pharmaceuticals,roche
['jiangsu hengrui']
in the mini oral session at the 2022 meeting, jiangsu hengrui demonstrated the result of the phila trial. get more insights at: #esmo2022 #esmo #esmo22 #breakthroughs #abstracts #oncology #event #clinicaltrials #clinicalresearch #cancer 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry